Adenosine A2a receptor antagonists

Details for Australian Patent Application No. 2001268089 (hide)

International Classifications

Event Publications

28 April 2005 Application Accepted

Published as AU-B-2001268089

25 August 2005 Standard Patent Sealed

17 November 2005 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 31 Aug 2005. Address for service in Australia - Griffith Hack Level 29 Northpoint Tower 100 Miller Street North Sydney NSW 2060

13 April 2006 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 31 Aug 2005

11 October 2012 Application for Amendment

The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.